Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV, page-245

Market needs clarity of the other results! Coming weeks for headline results should come with all headline results, and/or a clear dealine of the other results. COVID 19 results and analyses done long ago should have been released or at least its current status should be made public

Gilead being behind the scene and helping Biotron should have been made public and clear. Current management are not enough. Gilead representatives should directly come into the board decision and leadership directions. MM is not capable whasoever to communciate with the stakeholders. Biotron SHs need Gilead to take the leadership role of the Biotron, sending MM at an advisory role.

With so much promises, hype, and bluff, maket needs a capable leadership good at commercialization and communication ...

MM needs to go!